| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 08/29/2001 | EP1127869A1 Novel compounds and medicinal use thereof |
| 08/29/2001 | EP1127045A2 Use of triphenylbutene derivatives for the treatment of neurological disorders |
| 08/29/2001 | EP0809622B1 Anti-inflammatory benzoic acid derivatives |
| 08/29/2001 | EP0738260B1 Pesticides |
| 08/29/2001 | CN1310721A Medicine nitrate salts |
| 08/29/2001 | CN1310710A Processes for producing highly pure nicotinamide |
| 08/29/2001 | CN1310709A N.N-substituted cyclic amine derivatives |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310175A Process for producing bis (4-amino-1-pyridine) paraffins |
| 08/29/2001 | CN1309898A Pesticide containing 0-benzyl oximeether derivative and its use |
| 08/28/2001 | US6281362 Method for producing pyridine bases |
| 08/28/2001 | US6281231 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals |
| 08/28/2001 | US6281214 Biphenyl derivatives |
| 08/28/2001 | US6281209 Fungicidal alkoximinomethyldioxazine derivatives |
| 08/28/2001 | US6280706 Chelating agents |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/23/2001 | WO2001060822A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | WO2001060820A2 Matrix metalloproteinase inhibitors and uses thereof |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001060783A1 Phenacylamine derivatives, production thereof and pest controllers containing the derivatives |
| 08/23/2001 | WO2001060365A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/23/2001 | WO2001060349A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
| 08/23/2001 | WO2000071520A3 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors |
| 08/23/2001 | WO2000071508A3 Inhibitors of factor Xa |
| 08/23/2001 | WO2000063176A3 Disubstituted pyridines and pyrimidines as herbicides and fungicides |
| 08/23/2001 | US20010016660 Reacting difunctional alkanes containing halogen or aliphatic or aromataic sulfonyloxide reactive functional groups with 4-aminopyrimidine derivative in presence of water and organic solvent (alcohols, glycols, polyglycols, mono or diethers) |
| 08/23/2001 | US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/23/2001 | US20010016238 Electrooptical liquid crystal system |
| 08/23/2001 | CA2400537A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors |
| 08/23/2001 | CA2400197A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug |
| 08/23/2001 | CA2395841A1 Matrix metalloproteinase inhibitors and uses thereof |
| 08/22/2001 | EP1125931A1 Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof |
| 08/22/2001 | EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |
| 08/22/2001 | EP1125928A1 Transition metal compounds, catalysts for the production of alpha-olefins and process therefor |
| 08/22/2001 | EP1125927A1 A method for preparation of a quaternary ammonium salt |
| 08/22/2001 | EP1125926A1 Process for the preparation of 4-(4'-carboxyphenyl)pyridine |
| 08/22/2001 | EP1125582A2 Use of estrogen agonists / antagonists for the treatment of sexual dysfunction |
| 08/22/2001 | EP1125498A2 Spore germination inhibitor and food using the same |
| 08/22/2001 | EP1124821A1 Compounds |
| 08/22/2001 | EP1124803A1 Preparation of chloromethylpyridine hydrochlorides |
| 08/22/2001 | EP1124794A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 08/22/2001 | EP0946232B1 Crystallisation process |
| 08/22/2001 | CN1309635A Benzocycloheptenes, method for production thereof, pharmaceutical preparations contg. these compounds, and their use for producing medicaments |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309325A Photographic element, compound and method |
| 08/21/2001 | US6277885 Inhibitors of tumor necrosis factor-alpha converting enzyme |
| 08/21/2001 | US6277855 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 08/21/2001 | US6277849 N-sulphonyl and N-sulphinyl amino acid amides as microbiocides |
| 08/21/2001 | US6277536 Heterocyclic compounds |
| 08/21/2001 | US6277503 Containing a methylidene compound |
| 08/21/2001 | CA2083606C Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| 08/16/2001 | WO2001058874A1 Non-symmetrical ligands and catalyst systems thereof for ehtylene oligomerisation to linear alpha olefins |
| 08/16/2001 | WO2001058873A1 Method for producing 5-aryl nicotinaldehydes |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001012180A3 Peroxovanadium compounds as protein tyrosine phosphatase (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune responce |
| 08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 08/16/2001 | WO2001010381A3 Methods for treating or preventing pain and anxiety |
| 08/16/2001 | WO2001010380A3 Benzanilides as potassium channel openers |
| 08/16/2001 | WO2001009119A3 Chemokine receptor antagonists |
| 08/16/2001 | WO2001009096A3 Potassium channel openers |
| 08/16/2001 | WO2000059487A3 Flupirtine in the treatment of fibromyalgia and related conditions |
| 08/16/2001 | US20010014691 Nervous system disorders |
| 08/16/2001 | US20010014689 Nervous system disorders |
| 08/16/2001 | US20010014683 Analgesics; side effect reduction |
| 08/16/2001 | EP1123935A2 3'-Fluorinated guanosine derivatives for the treatment or prophylaxis of HBV or retroviral infections |
| 08/16/2001 | EP1123933A1 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent |
| 08/16/2001 | EP1123927A1 Process for the preparation of bis-(4-amino-1-pyridinium)-alkanes |
| 08/16/2001 | EP1123926A1 Piperazine derivatives for treatment of CNS disorders |
| 08/16/2001 | EP1123925A1 Process for preparation of substituted pyridines |
| 08/16/2001 | EP1123924A1 Substituted pyridines as HMG-COA reductase inhibitors |
| 08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 08/16/2001 | EP1123303A1 Polymerisation catalyst |
| 08/16/2001 | EP1123287A1 Insecticidal 3- (substituted pyridyl) -1, 2, 4-triazoles |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP0805817B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 08/16/2001 | EP0787719B1 Conjugated n-fluoropyridinium salt polymer and use thereof |
| 08/16/2001 | DE10006601A1 Verfahren zur Herstellung von 4-(4'-Carboxyphenyl)pyridin Process for the preparation of 4- (4'-carboxyphenyl) pyridine |
| 08/16/2001 | CA2398968A1 Non-symmetrical ligands and catalyst systems thereof for ehtylene oligomerisation to linear alpha olefins |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/15/2001 | CN1308629A Reduced partide size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl] piperazine |
| 08/15/2001 | CN1308628A Method for preparing 4-(3-pyridinyl)-1H-imidazole and the inter medicates used |
| 08/15/2001 | CN1308608A Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1308074A Chiralheteraryl cyan alcohol and its derivative, preparation and use |
| 08/15/2001 | CN1308064A Flowable niacinamide-containing powder and its production process |
| 08/15/2001 | CN1308063A Production process of heterocyclic nitrile |
| 08/14/2001 | US6274806 Dye sensitized electrode of a substrate with electrical conductive surface, an oxide semiconductor film formed on it, which supports a platinum complex |
| 08/14/2001 | US6274758 Enantiomorph selectivity |
| 08/14/2001 | US6274735 Process and intermediates for preparation of substituted piperidines |
| 08/14/2001 | US6274606 Methods of treating central nervous system disorders with aryl substituted olefinic amine compounds |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay |
| 08/14/2001 | CA2335703A1 A method for preparation of a quaternary ammonium salt |
| 08/14/2001 | CA2129013C Pyridinecarboximidamide compounds and the use thereof |